EXPRESSION OF P53 OR CYTOPLASMIC NUCLEOPHOSMINE ASSOCIATED WITH INCREASED RISK OF DISEASE PROGRESSION IN MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q)

被引：0
|
作者：
Jadersten, M. S. [1 ]
Saft, L. [1 ]
Garelius, H. [2 ]
Hast, R. [1 ]
Nilsson, L. [3 ]
Samuelsson, J. [4 ]
Porwit, A. [1 ]
Hellstrom-Lindberg, E. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Sahlgrens Univ Hosp, Gothenburg, Sweden
[3] Univ Lund Hosp, S-22185 Lund, Sweden
[4] Soder Sjukhuset, Stockholm, Sweden
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0257
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [1] Expression of p53 or cytoplasmic nucleophosmine associated with increased risk of disease progression in myelodysplastic syndrome with isolated del(5q)
    Jadersten, M.
    Saft, L.
    Garelius, H.
    Hast, R.
    Nilsson, L.
    Samuelsson, J.
    Porwit, A.
    Hellstrom-Lindberg, E.
    LEUKEMIA RESEARCH, 2009, 33 : S39 - S39
  • [2] Bone marrow morphology in myelodysplastic syndrome associated with isolated del(5q)
    Naresh, Kikkeri N.
    Reid, Alistair
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (08) : 609 - 610
  • [3] DETECTION OF TP53 MUTATIONS IN LOW-RISK MYELODYSPLASTIC SYNDROMES WITH DEL(5Q) IS ASSOCIATED WITH DISEASE PROGRESSION
    Jadersten, M.
    Saft, L.
    Smith, A.
    Kulasekararaj, A.
    Pomplun, S.
    Hast, R.
    Porwit, A.
    Hellstrom-Lindberg, E.
    Mufti, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 126 - 126
  • [4] p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
    Saft, Leonie
    Karimi, Mohsen
    Ghaderi, Mehran
    Matolcsy, Andras
    Mufti, Ghulam J.
    Kulasekararaj, Austin
    Goehring, Gudrun
    Giagounidis, Aristoteles
    Selleslag, Dominik
    Muus, Petra
    Sanz, Guillermo
    Mittelman, Moshe
    Bowen, David
    Porwit, Anna
    Fu, Tommy
    Backstrom, Jay
    Fenaux, Pierre
    MacBeth, Kyle J.
    Hellstrom-Lindberg, Eva
    HAEMATOLOGICA, 2014, 99 (06) : 1041 - 1049
  • [5] TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
    Jaedersten, Martin
    Saft, Leonie
    Smith, Alexander
    Kulasekararaj, Austin
    Pomplun, Sabine
    Goehring, Gudrun
    Hedlund, Anette
    Hast, Robert
    Schlegelberger, Brigitte
    Porwit, Anna
    Hellstrom-Lindberg, Eva
    Mufti, Ghulam J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 1971 - 1979
  • [6] Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)
    Butrym, Aleksandra
    Lech-Maranda, Ewa
    Patkowska, Elzbieta
    Kumiega, Beata
    Bieniaszewska, Maria
    Mital, Andrzej
    Madry, Krzysztof
    Torosian, Tigran
    Wichary, Ryszard
    Rybka, Justyna
    Warzocha, Krzysztof
    Mazur, Grzegorz
    BMC CANCER, 2015, 15
  • [7] Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)
    Aleksandra Butrym
    Ewa Lech-Maranda
    Elżbieta Patkowska
    Beata Kumiega
    Maria Bieniaszewska
    Andrzej Mital
    Krzysztof Madry
    Tigran Torosian
    Ryszard Wichary
    Justyna Rybka
    Krzysztof Warzocha
    Grzegorz Mazur
    BMC Cancer, 15
  • [8] Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation
    Muto, Tomoya
    Walker, Callum S.
    Agarwal, Puneet
    Vick, Eric
    Sampson, Avery
    Choi, Kwangmin
    Niederkorn, Madeline
    Ishikawa, Chiharu
    Hueneman, Kathleen
    Varney, Melinda
    Starczynowski, Daniel T.
    HAEMATOLOGICA, 2023, 108 (10) : 2715 - 2729
  • [9] A Novel Case of Myelodysplastic Syndrome With Isolated del(5q) and Concomitant CALR Mutation
    Ameri, Maryam Dadfarnia
    Chen, Chien-Shing
    Wang, Jun
    Rowsell, Edward
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A122 - A122
  • [10] RESPONSE TO THALIDOMIDE AND CYCLOSPORINE IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROME WITHOUT ISOLATED DEL(5Q)
    Wang, J.
    Qin, T.
    Xu, Z.
    Zhang, Y.
    Gale, R.
    Fang, L.
    Zhang, H.
    Pan, L.
    Hu, N.
    Qu, S.
    Li, B.
    Xiao, Z.
    LEUKEMIA RESEARCH, 2015, 39 : S127 - S127
12345